Brief: Parabilis Medicines Initiates Dose-Ranging Clinical Study Of Zolucatetide In Familial Adenomatous Polyposis14/10/2026 13:37
Brief: Parabilis Medicines Reports Second Quarter 2026 Financial Results And Provides Business Updates13/08/2026 12:24
Last trade - 00:00Last trade - 00:00Last trade - 00:00